The pharmaceutical industry is rapidly evolving, with increasing demand for high-quality Active Pharmaceutical Ingredients (APIs). Dulaglutide, a diabetes drug, stands as copyrightple of this trend. To fulfill this demand, US-based manufacturing services are gaining traction. These companies offer a w